New diabetes clinical trial: A Study of CJC-1134-PC Injection in Patients With Type 2 Diabetes With Inadequately Controlled Blood Glucose Level After Metformin Monotherapy or Metformin in Combination With Insulin Secretagogues

Published on: July 08, 2025 at 11:00PM
Conditions: Type 2 Diabetes Mellitus - Poor Control
Interventions: Drug: CJC-1134-PC Injection; Drug: Placebo
Sponsors: Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.
Completed
https://ift.tt/76rChvf

Comments